Jefferies Group’s Tandem Diabetes Care TNDM Stock Holding History

Jefferies Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$317K	Buy	+6,630	New	+$363K	﹤0.01%	1206
2019 Q4	–	Sell	-11,578	Closed	-$683K	–	2999
2019 Q3	$683K	Buy	+11,578	New	+$739K	0.01%	1720
2019 Q2	–	Sell	-6,375	Closed	-$405K	–	2866
2019 Q1	$405K	Buy	+6,375	New	+$335K	﹤0.01%	1687
2018 Q4	–	Sell	-11,443	Closed	-$490K	–	2567
2018 Q3	$490K	Buy	+11,443	New	+$400K	﹤0.01%	1643
2015 Q3	–	Sell	-44	Closed	-$5K	–	3014
2015 Q2	$5K	Sell	44 -2,041	-98%	-$254K	﹤0.01%	2996
2015 Q1	$263K	Buy	+2,085	New	+$271K	﹤0.01%	1652

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's TNDM Position: Q3 2022 in Review

Jefferies Group opened a new position in Tandem Diabetes Care (TNDM) in Q3 2022: 6,630 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #1206 among its holdings. This is a return to the name: Jefferies Group previously reported a position in TNDM as recently as Q3 2019.

Jefferies Group first reported a position in TNDM in Q1 2015 and has held it in 6 quarters since. The position peaked at $683K in Q3 2019. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

Jefferies Group held 6,630 shares of Tandem Diabetes Care worth $317K as of Q3 2022.
Tandem Diabetes Care was a new Jefferies Group position in Q3 2022.
Tandem Diabetes Care made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1206 holding.
Jefferies Group first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 6 quarters since.
Jefferies Group's Tandem Diabetes Care position peaked at $683K in Q3 2019.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.